Page last updated: 2024-11-02

1,7-dimethylxanthine and Cardiovascular Diseases

1,7-dimethylxanthine has been researched along with Cardiovascular Diseases in 2 studies

1,7-dimethylxanthine : A dimethylxanthine having the two methyl groups located at positions 1 and 7. It is a metabolite of caffeine and theobromine in animals.

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research Excerpts

ExcerptRelevanceReference
"Some recent epidemiologic studies have reported a nonlinear dose-response in the relationship between coffee consumption and health risks, such that the risks increase disproportionately to the increase in dose."2.67Dose-dependency of caffeine metabolism with repeated dosing. ( Benowitz, NL; Brown, CR; Denaro, CP; Jacob, P; Wilson, M, 1990)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Y1
Tu, JH1
He, YJ1
Zhang, W1
Wang, G1
Tan, ZR1
Zhou, G1
Fan, L1
Zhou, HH1
Denaro, CP1
Brown, CR1
Wilson, M1
Jacob, P1
Benowitz, NL1

Trials

1 trial available for 1,7-dimethylxanthine and Cardiovascular Diseases

ArticleYear
Dose-dependency of caffeine metabolism with repeated dosing.
    Clinical pharmacology and therapeutics, 1990, Volume: 48, Issue:3

    Topics: Adult; Caffeine; Cardiovascular Diseases; Coffee; Dose-Response Relationship, Drug; Female; Humans;

1990

Other Studies

1 other study available for 1,7-dimethylxanthine and Cardiovascular Diseases

ArticleYear
Effect of sodium tanshinone II A sulfonate on the activity of CYP1A2 in healthy volunteers.
    Xenobiotica; the fate of foreign compounds in biological systems, 2009, Volume: 39, Issue:7

    Topics: Adolescent; Adult; Caffeine; Cardiovascular Diseases; Cytochrome P-450 CYP1A2; Enzyme Activation; Hu

2009